Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Host-pathogen interactions during ESKAPE-mediated urinary tract infections and ventilator-associated pneumonia: a review.

Created on 09 Jul 2026

Authors

Tejpal Sharma, Pankaj Chandley

Published in

Folia microbiologica. Jul 09, 2026. Epub Jul 09, 2026.

Abstract

Antimicrobial resistance (AMR) represents one of the most critical healthcare concerns worldwide, specifically amplified by the ESKAPE pathogens, which represent the six most nosocomial pathogens: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species. The ESKAPE pathogens pose a crucial challenge due to their unique ability to acquire resistance to most of the currently available drugs. Globally, a serious and alarming prevalence trajectory of ESKAPE pathogens has been seen, responsible for healthcare-associated infections, such as urinary tract infection (UTI) and ventilator-associated pneumonia (VAP). These infections are considered one of the major contributors to morbidity and mortality rates worldwide. This review highlights an emerging trend of AMR associated with UTI and VAP in hospital settings. Furthermore, this review discusses the key mediators of host immune response against ESKAPE pathogens involved in causing UTI and VAP. Developing specific therapeutics and enhancing antimicrobial stewardship strategies against these pathogens may contribute to curbing the growing menace of AMR.

PMID:
42423835
Bibliographic data and abstract were imported from PubMed on 09 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement